|
|
|
|
||
Re: I think the peer review is taking so long-billmax If no announcements are made today, I will not invest more into Inovio. There are too many unanswered questions and the company can not or doesn't want to answer them. Long term INO still has a shot at being a solid company. Short term, all rests on Covid Vaccine, which will not produce large revenue. |
return to message board, top of board |